Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis

Abstract

Purpose The polycystic ovary syndrome (PCOS) is a reproductive endocrine disorder, clinically characterized by oligo-ovulation/chronic anovulation, menstrual irregularities, hyperandrogenism (such as hirsutism, acne), hyperinsulinemia, and obesity. Prostatic-specific antigen (PSA) has been identified as a potential new marker in PCOS women. Although the precise role of PSA in PCOS patients still remains undetermined, PSA might serve as a useful clinical marker and might even represent a new diagnostic criterion of hyperandrogenemia in females of PCOS. Methods A meta-analysis was performed in the study to identify the association between the polycystic ovary syndrome and prostatic-specific antigen. To identify eligible original articles, we searched a range of computerized databases, including Medline via PubMed, EMBASE, CNKI and Web of Science with a systematic searching strategy. The characteristics of each study and standard mean differences (SMD) with corresponding confidence intervals (CIs) were calculated and subgroup analysis was performed to analyze heterogeneity. Results A total of 532 patients from seven articles were included in the meta-analysis. We identified a significant relationship between polycystic ovary syndrome and prostatic-specific antigen, with a pooled SMD of 0.81 (95% CI: 0.58 to 1.04; P < 0.01). The pooled data were calculated with the random-effects model as a moderate significant heterogeneity was found among the studies. Conclusions The meta-analysis suggested that there was a significant association between the polycystic ovary syndrome and prostatic-specific antigen and we should not ignore the role of PSA in the PCOS patients in clinical.

Factors influencing blood tumor marker concentrations in the absence of neoplasia

“…Finally, it should be noted that in women, serum PSA levels are related to androgenic activity [219]. For example, patients with polycystic ovary syndrome present high levels of PSA and its fractions, which may therefore have some clinical value [220,221].…”

BPA Replacement Compounds: Current Status and Perspectives

“…A great variety of computational toxicology methodologies have been developed and applied in drug discovery, risk assessment of chemicals, and safety evaluation of products. − Because these studies regarding public health effects and safe manipulation of BPA replacement compounds are still extremely limited, computational predictive modeling becomes a very important tool for searching safe BPA replacement compounds and performing their safety evaluations. For example, researchers have developed a variety of computational models to predict the endocrine-disrupting potential, testicular toxicity, estrogen and androgen receptor binding activities, and the underlying molecular mechanisms, − metabolism, and probabilistic risk assessments of BPA and its analogues .…”

Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism

“…Inflammation is also one of the risk factors, and any disturbance of the level of inflammatory factors may lead to the dysfunction of ovarian function ( 10 ). In addition, a meta-analysis suggested a significant correlation between PCOS and prostate-specific antigen (PSA), and the role of PSA in patients with PCOS cannot be ignored clinically ( 11 ).…”